Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y, Tsuburaya A
3rd Dept. of Surgery, Kanagawa Cancer Center.
Gan To Kagaku Ryoho. 1998 Jul;25(9):1461-4.
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in peripheral blood were measured in 54 patients with gastric carcinoma; 46 were primary and 8 were recurrent cases. There were no significant associations between MMP-9 concentrations and clinicopathological factors. TIMP-1 levels were significantly increased in advanced and recurrent cases, and in cases with peritoneal dissemination and lymph node metastasis, suggesting that TIMP-1 concentration in the peripheral blood could be a new tumor marker for the recurrence of gastric carcinoma.
对54例胃癌患者外周血中的基质金属蛋白酶-9(MMP-9)和基质金属蛋白酶组织抑制剂-1(TIMP-1)进行了检测;其中46例为原发性病例,8例为复发性病例。MMP-9浓度与临床病理因素之间无显著关联。TIMP-1水平在晚期和复发性病例以及有腹膜播散和淋巴结转移的病例中显著升高,提示外周血中TIMP-1浓度可能是胃癌复发的一种新的肿瘤标志物。